Cellebrite Newsroom

William Blair Maintains Cellebrite(CLBT.US) With Buy Rating

Moomoo NewsDec 16 18:31 ET

Cellebrite DI: Strategic Focus on Inseyets Platform and Complementary Applications Drive Buy Rating With Over 20% Upside Potential

TipRanksDec 16 17:47 ET

Cellebrite DI Is Maintained at Overweight by JP Morgan

Dow JonesDec 16 08:57 ET

Cellebrite DI Price Target Raised to $24.00/Share From $22.00 by JP Morgan

Dow JonesDec 16 08:57 ET

Cellebrite DI Analyst Ratings

BenzingaDec 16 08:48 ET

J.P. Morgan Maintains Cellebrite(CLBT.US) With Buy Rating, Raises Target Price to $24

Moomoo NewsDec 16 07:31 ET

TD Cowen Maintains Cellebrite(CLBT.US) With Buy Rating, Raises Target Price to $25

Moomoo NewsDec 6 14:32 ET

Craig-Hallum Maintains Cellebrite(CLBT.US) With Buy Rating

Moomoo NewsNov 25 10:33 ET

J.P. Morgan Maintains Cellebrite(CLBT.US) With Buy Rating, Raises Target Price to $22

Moomoo NewsNov 8 13:32 ET

Lake Street Maintains Cellebrite(CLBT.US) With Buy Rating, Raises Target Price to $21

Moomoo NewsNov 7 09:31 ET

Craig-Hallum Maintains Cellebrite(CLBT.US) With Buy Rating, Announces Target Price $24

Moomoo NewsNov 7 09:31 ET

Cellebrite DI Is Maintained at Buy by Needham

Dow JonesNov 7 05:00 ET

Cellebrite DI Analyst Ratings

BenzingaNov 7 04:50 ET

William Blair Maintains Cellebrite(CLBT.US) With Buy Rating

Moomoo NewsNov 6 15:31 ET

Needham Maintains Cellebrite(CLBT.US) With Buy Rating, Raises Target Price to $21

Moomoo NewsNov 6 12:32 ET

Cellebrite DI: Strong Performance and Promising Outlook Justify Buy Rating Despite Leadership Transition Concerns

TipRanksNov 6 11:40 ET

Craig-Hallum Maintains Cellebrite(CLBT.US) With Buy Rating

Moomoo NewsNov 6 09:34 ET

J.P. Morgan Remains a Buy on Cellebrite DI (CLBT)

TipRanksNov 5 07:19 ET

Craig-Hallum Maintains Cellebrite(CLBT.US) With Buy Rating

Moomoo NewsNov 4 09:34 ET

BofA Securities Maintains Cellebrite(CLBT.US) With Buy Rating

Moomoo NewsOct 23 09:31 ET